Your browser doesn't support javascript.
loading
Prevalence of Multidrug-Resistant Tuberculosis in HIV/Tuberculosis Co-Infected Patients / 감염과화학요법
Infection and Chemotherapy ; : 792-795, 2021.
Article in En | WPRIM | ID: wpr-914615
Responsible library: WPRO
ABSTRACT
Tuberculosis (TB) is a common opportunistic infection in human immunodeficiency virus (HIV)-infected patients. Patients with multidrug-resistant (MDR)-TB have poor outcomes.This study aimed to determine the prevalence of MDR-TB in HIV/TB co-infected patients in the Korea. We reviewed the medical records of HIV/TB co-infected patients at two university hospitals between January 1998 and December 2020. During the study period, a total of 87 HIV/TB co-infected patients were identified, and drug susceptibility test results were available for 44 of them. The prevalence of MDR-TB in the study population was 15.9% (7/44, 95% confidence interval, 5.1 - 26.7).
Full text: 1 Index: WPRIM Type of study: Prevalence_studies Language: En Journal: Infection and Chemotherapy Year: 2021 Type: Article
Full text: 1 Index: WPRIM Type of study: Prevalence_studies Language: En Journal: Infection and Chemotherapy Year: 2021 Type: Article